Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Changes in dementia diagnoses in Sweden during the COVID-19 pandemic

View through CrossRef
Abstract Introduction The COVID-19 pandemic has caused large disruptions to healthcare systems. Refocus on COVID-19 related care might have contributed to indirect effects on other healthcare areas. Care focused on acute conditions have been negatively affected although research into the effects on chronic and care intensive patient groups such as patients with dementia diseases is lacking. In this study we evaluated dementia diagnosis trends in Sweden during 2015–2020 according to International Classification of Disease version 10 coding of common dementia diseases. Methods Regional and national statistics in the form of International Classification of Disease version 10 coding, COVID-19 incidence, mortality data, and population census data were collected from the National Institute of Health and Welfare. Logistic regression analysis was performed to identify trends of dementia diagnosis during 2015–2020. Correlation test was performed between COVID-19 incidence, mortality rates, and dementia coding. Results Dementia diagnosis incidence has been declining since 2015 and further decline was noted in many regions in Sweden during 2020. As COVID-19 incidence increased, fewer cases of dementia were diagnosed, a decrease that differentially impacted women and those who were advanced in age. Conclusions Dementia diagnosis incidence in Sweden has been on a decline since 2015. The COVID-19 pandemic caused a further larger decline in dementia diagnosis incidence during 2020. COVID-19 incidence, but not mortality, was associated with decrease in dementia diagnosis incidence. There might be a large number of undiagnosed patients with dementia and healthcare reforms should be enacted to address this. Women and elderly are particularly vulnerable groups.
Title: Changes in dementia diagnoses in Sweden during the COVID-19 pandemic
Description:
Abstract Introduction The COVID-19 pandemic has caused large disruptions to healthcare systems.
Refocus on COVID-19 related care might have contributed to indirect effects on other healthcare areas.
Care focused on acute conditions have been negatively affected although research into the effects on chronic and care intensive patient groups such as patients with dementia diseases is lacking.
In this study we evaluated dementia diagnosis trends in Sweden during 2015–2020 according to International Classification of Disease version 10 coding of common dementia diseases.
Methods Regional and national statistics in the form of International Classification of Disease version 10 coding, COVID-19 incidence, mortality data, and population census data were collected from the National Institute of Health and Welfare.
Logistic regression analysis was performed to identify trends of dementia diagnosis during 2015–2020.
Correlation test was performed between COVID-19 incidence, mortality rates, and dementia coding.
Results Dementia diagnosis incidence has been declining since 2015 and further decline was noted in many regions in Sweden during 2020.
As COVID-19 incidence increased, fewer cases of dementia were diagnosed, a decrease that differentially impacted women and those who were advanced in age.
Conclusions Dementia diagnosis incidence in Sweden has been on a decline since 2015.
The COVID-19 pandemic caused a further larger decline in dementia diagnosis incidence during 2020.
COVID-19 incidence, but not mortality, was associated with decrease in dementia diagnosis incidence.
There might be a large number of undiagnosed patients with dementia and healthcare reforms should be enacted to address this.
Women and elderly are particularly vulnerable groups.

Related Results

Exploring the Impact of Coronavirus Disease 2019 on Dementia: A Review
Exploring the Impact of Coronavirus Disease 2019 on Dementia: A Review
The coronavirus disease 2019 (COVID-19) pandemic has caused significant disruptions to almost every healthcare system worldwide. Older adults have been hit disproportionately hard ...
Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
Abstract Pharmacotherapy of dementia is a critical intervention for managing symptoms of and slowing progression of dementia. However, evidence on prescribing patter...
MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia
MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia
AbstractBackgroundApathy, characterized by decreased interest, initiative, and emotional reactivity, is amongst the most common neuropsychiatric symptoms in dementia. However, apat...
Prevalence, Factors Associated and Knowledge of Dementia in a Sample of Older Ugandans
Prevalence, Factors Associated and Knowledge of Dementia in a Sample of Older Ugandans
Abstract Introduction:Dementia is on the rise due to increasing proportion of old people in Sub-Saharan Africa (SSA). Although dementia is misattributed to normal ageing or...
Monthly mortality from Alzheimer’s disease and other dementia in Japan
Monthly mortality from Alzheimer’s disease and other dementia in Japan
AbstractBackgroundThe aim of this study is to research seasonal changes in dementia mortality in Japan and to pursue the excess death on COVID‐19. COVID‐19 excess mortality were hi...
Development and Evaluation of a Clinician-Vetted Dementia Caregiver Resources Website: Mixed Methods Approach (Preprint)
Development and Evaluation of a Clinician-Vetted Dementia Caregiver Resources Website: Mixed Methods Approach (Preprint)
BACKGROUND About 11 million Americans are caregivers for the 6.7 million Americans currently living with dementia. They provide over 18 billion hours of unp...

Back to Top